Asia Pac Allergy.  2015 Jul;5(3):181-186. 10.5415/apallergy.2015.5.3.181.

Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next?

• Kang SY
• Sohn KH
• Lee JO
• Kim SH
• Cho SH
• Chang YS

• KMID: 2397049
• DOI: http://doi.org/10.5415/apallergy.2015.5.3.181

Abstract

Tacrolimus and cyclosporine have been used in various formulations, but their hypersensitivity reactions are rare in practice. Castor oil derivatives are nonionic surfactants used in aqueous preparations of hydrophobic active pharmaceutical ingredients. Castor oil derivatives that can be used as additives to tacrolimus and cyclosporine may play a role in the development of hypersensitivity reactions, especially anaphylaxis. Various immunologic and nonimmunologic mechanisms have been implicated in hypersensitivity reactions induced by castor oil derivatives. Physicians should be aware that not only the drug itself, but also its additives or metabolites could induce hypersensitivity reactions. We report a case of anaphylaxis caused by vitamin K (phytonadine), serotonin antagonist (granisetron), intravenous tacrolimus, and cyclosporine. Interestingly, the patient tolerated oral cyclosporine, which did not contain Cremophor EL or polysorbate 80.

Keyword

Anaphylaxis; Tacrolimus; Cyclosporine; Polyethoxylated Castor Oil; Cremophor; Polysorbates

MeSH Terms

Anaphylaxis*
Castor Oil
Cyclosporine*
Humans
Hypersensitivity
Polysorbates
Serotonin
Surface-Active Agents
Tacrolimus*
Vitamin K
Castor Oil
Cyclosporine
Polysorbates
Serotonin
Surface-Active Agents
Tacrolimus
Vitamin K

Reference

1. Fay JW, Wingard JR, Antin JH, Collins RH, Pineiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. Blood. 1996; 87:3514–3519.

2. Ringden O. Cyclosporine in allogeneic bone marrow transplantation. Transplantation. 1986; 42:445–452.

3. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004; 21:201–230.

4. Kessell J, Assem ES. Letter: An adverse reaction to althesin. Br J Anaesth. 1974; 46:209.

5. Nicolai S, Bunyavanich S. Hypersensitivity reaction to intravenous but not oral tacrolimus. Transplantation. 2012; 94:e61–e63.

6. Takamatsu Y, Ishizu M, Ichinose I, Ogata K, Onoue M, Kumagawa M, Suzumiya J, Tamura K. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant. 2001; 28:421–423.

7. Volcheck GW, Van Dellen RG. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review. Ann Allergy Asthma Immunol. 1998; 80:159–163.

8. Friedland D, Gorman G, Treat J. Hypersensitivity reactions from taxol and etoposide. J Natl Cancer Inst. 1993; 85:2036.

9. Weiszhár Z, Czucz J, Revesz C, Rosivall L, Szebeni J, Rozsnyay Z. Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20. Eur J Pharm Sci. 2012; 45:492–498.

10. Ebo DG, Piel GC, Conraads V, Stevens WJ. IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Ann Allergy Asthma Immunol. 2001; 87:243–245.

11. Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005; 216:106–121.

12. Gaudy JH, Sicard JF, Lhoste F, Boitier JF. The effects of cremophor EL in the anaesthetized dog. Can J Anaesth. 1987; 34:122–129.

13. Cooney GF, Alpern JB, Narins BE, Goetz LK, Cavarocchi NC. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug. Transplantation. 1990; 49:823–824.

14. van Hooff JP, Bessems P, Beuman GH, Leunissen KM. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine. Transplant Proc. 1988; 20:2 Suppl 2. 640.

15. Kuiper RA, Malingré MM, Beijnen JH, Schellens JH. Cyclosporine-induced anaphylaxis. Ann Pharmacother. 2000; 34:858–861.

16. Michaud LB. Methods for preventing reactions secondary to Cremophor EL. Ann Pharmacother. 1997; 31:1402–1404.

17. Bristol-Myers Squibb. Prescribing information for Ixempra kit (ixabepilone) Injection 2011 [Internet]. Princeton (NJ): Bristol-Myers Squibb;c2015. cited 2015 Jul 10. Available from: http://packageinserts.bms.com/pi/pi_ixempra.pdf.

18. AbbVie. Prescribing information for Kaletra (Lopinavir and Ritonavir) tablets and oral solution [Internet]. North Chicago (IL): AbbVie;c2015. cited 2015 Jul 10. Available from: http://www.rxabbvie.com/pdf/kaletratabpi.pdf.

19. AbbVie. Prescribing information for Norvir (ritonavir) soft gelatin capsules, tablets and oral solution [Internet]. North Chicago (IL): AbbVie;c2015. cited 2015 Jul 10. Available from: http://norvir.com/important-safety-information.cfm.

20. Hospira. Phytonadione (vitamin K1) injectable emulsion safety data sheet [Internet]. Lake Forest (IL): Hospira;c2015. cited 2015 Jul 10. Available from: http://www.hospira.com/en/search?q=phytonadione&fq=on.

21. Novartis AG. Package leaflet: information for the user for Tegretol [Internet]. Basel (CH): Novartis AG;c2015. cited 2015 Jul 10. Available from: http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1412572274774.pdf.

22. Novartis Pharmaceuticals UK Ltd. Package leaflet: information for the user for Anafranil [Internet]. West Sussex (UK): Novartis Pharmaceuticals UK Ltd.;c2015. cited 2015 Jul 10. Available from: http://www.medicines.org.uk/emc/PIL.21096.latest.pdf.

23. Wyeth Pharmaceuticals Inc.a subsidiary of Pfizer Inc.Prescribing information for Torisel (temsirolimus) kit Injection [Internet]. New York: Pfizer;c2015. cited 2015 Jul 10. Available from: http://labeling.pfizer.com/showlabeling.aspx?id=490.

24. Hoffmann-La Roche Ltd.Consumer information for Kytril (granisetron) tablets [Internet]. Mississauga (ON): Hoffmann-La Roche Ltd.;c2015. cited 2015 Jul 10. Available from: http://www.rochecanada.com/content/dam/internet/corporate/rochecanada/en_CA/documents/Research/ClinicalTrialsForms/Products/ConsumerInformation/MonographsandPublicAdvisories/Kytril/Kytril_PM_CIE.pdf.

25. Genentech Inc. Prescribing information for Pegasys (peginterferon alfa-2a) Injection [Internet]. San Francisco (CA): Genentech Inc.;c2015. cited 2015 Jul 10. Available from: http://www.gene.com/download/pdf/pegasys_prescribing.pdf.

26. Wolters Kluwer Health. Vaccine excipient and media summary (CDC). St Louis (MO): Wolters Kluwer Health;c2015. cited 2015 Jul 10. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf.

27. AbbVie. Prescribing information for Humira (adalimumab) [Internet]. North Chicago (IL): AbbVie;c2015. cited 2015 Jul 10. Available from: http://www.rxabbvie.com/pdf/humira.pdf.

28. Janssen Biotech Inc. Prescribing information for Remicade (infliximab) [Internet]. Horsham (PA): Janssen Biotech Inc.;c2015. cited 2015 Jul 10. Available from: http://www.remicade.com/shared/product/remicade/prescribing-information.pdf.

29. Genentech Inc. Prescribing information for Actemra (tocilizumab) [Internet]. San Francisco (CA): Genentech Inc.;c2015. cited 2015 Jul 10. Available from: http://www.gene.com/download/pdf/actemra_prescribing.pdf.

30. Human Genome Sciences, Inc. Prescribing information for Benlysta (belimumab) [Internet]. Rockville (MD): Human Genome Sciences Inc., a subsidiary of GlaxoSmithKline;c2015. cited 2015 Jul 10. Available from: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Benlysta/pdf/BENLYSTA-PI-MG.PDF.

31. Genzyme Corp. Prescribing information for Lemtrada (alemtuzumab) [Internet]. Cambridge (MA): Genzyme Corp.;c2015. cited 2015 Jul 10. Available from: http://products.sanofi.us/lemtrada/lemtrada.pdf.

32. Biogen Idec Inc. Prescribing information for Tysabri (natalizumab) [Internet]. Cambridge (MA): Biogen Idec Inc.;c2015. cited 2015 Jul 10. Available from: http://www.tysabri.com/prescribingInfo.

33. Novartis Pharmaceuticals Corp. Prescribing information for Ilaris (canakinumab) [Internet]. East Hanover (NJ): Novartis Pharmaceuticals Corp.;c2015. cited 2015 Jul 10. Available from: http://www.pharma.us.novartis.com/product/pi/pdf/ilaris.pdf.